搜索筛选:
搜索耗时0.0769秒,为你在为你在102,285,761篇论文里面共找到 4 篇相符的论文内容
发布年度:
[会议论文] 作者：Xi Huang,Enfan Zhang,Haimeng Yan,Yang Liu,Jianwei Qu,Zhen Cai,
来源：2019中国肿瘤学大会 年份：2019
...
CCL2 promotes macrophage-associated chemoresistance via MCPIP1 dual catalytic activities in multiple
[会议论文] 作者：Ruyi Xu,Yi Li,Haimeng Yan,Enfan Zhang,Xi Huang,Zhen Cai,
来源：2019中国肿瘤学大会 年份：2019
Objective Multiple myeloma(MM)is an incurable hematologic malignancy characterized by the accumulation of monoclonal plasma cells in the BM,which often leads to bone lesions,renal disease,and immunode...
[期刊论文] 作者：Ruyi Xu,Yi Li,Yang Liu,Jianwei Qu,Wen Cao,Enfan Zhang,Jingsong He,Zhen Cai,
来源：蛋白质与细胞 年份：2020
Cytokines are secreted by various cell types and act as critical mediators in many physiological processes,including immune response and tumor progression.Cytok...
,Pirh2 mediates the sensitivity of myeloma cells to bortezomib via canonical NF-κB signaling pathway
[期刊论文] 作者：Li Yang,Jing Chen,Xiaoyan Han,Enfan Zhang,Xi Huang,Xing Guo,Qingxiao Chen,Wenjun Wu,Gaofeng Zheng,Donghua,
来源：蛋白质与细胞 年份：2018
Clinical success of the proteasome inhibitor established bortezomib as one of the most effective drugs in treatment of multiple myeloma (MM).While survival bene...
相关搜索：
